Latest News in the pharma Industry

Biopharma News

New dedicated biopharma event launches alongside CPhI Worldwide 2018 in Madrid

New dedicated biopharma event launches alongside CPhI Worldwide 2018 in Madrid

26 Oct 2017

New event to create unique synergies between the parallel worlds of large, small molecules and contract services.

Read more 
Catalent completes acquisition of Cook Pharmica

Catalent completes acquisition of Cook Pharmica

24 Oct 2017

Two new focused business units for biologics and oral drug delivery, to help customers accelerate drug development programs.

Read more 
Batavia expands its viral vector and cleanroom facilities to stay on top of demand

Batavia expands its viral vector and cleanroom facilities to stay on top of demand

16 Oct 2017

Investments will help the company to bring candidate biopharmaceuticals from bench to clinic.

Read more 
Construction starts for Sartorius' new Cell Culture Technology Centre

Construction starts for Sartorius' new Cell Culture Technology Centre

2 Oct 2017

The 30-million-euro investment will accommodate the growing needs of customers.

Read more 
PnuVax awarded $29.4 million grant to advance innovative vaccine into clinical trials

PnuVax awarded $29.4 million grant to advance innovative vaccine into clinical trials

2 Oct 2017

Use of PnuVax’s unique patented conjugation platform technology to produce the vaccine is expected to speed up biomanufacturing and increase yield for a greatly reduced per-dose cost.

Read more 
3SBio accelerates expansion of its global biologics platform

3SBio accelerates expansion of its global biologics platform

3 Sep 2017

The Chinese biopharmaceutical company acquires the Canadian biomanufacturing business of Therapure.

Read more 
Bayer submits BLA in the for BAY94-9027 – a long-acting factor VIII for the treatment of hemophilia A

Bayer submits BLA in the for BAY94-9027 – a long-acting factor VIII for the treatment of hemophilia A

3 Sep 2017

Pivotal studies with BAY94-9027 showed that bleed protection was achieved with extended dosing intervals.

Read more 
Merck successfully closes biosimilars transaction

Merck successfully closes biosimilars transaction

1 Sep 2017

Step towards strategic alignment of R&D resources to Healthcare priorities.

Read more 
Biogen’s adalimumab biosimilar referencing Humira, is approved in the EU

Biogen’s adalimumab biosimilar referencing Humira, is approved in the EU

28 Aug 2017

Biogen becomes the first company with approved biosimilars for the three most prescribed anti-TNF biologic treatments in Europe.

Read more 
Boehringer Ingelheim receives FDA approval for its Humira biosimilar

Boehringer Ingelheim receives FDA approval for its Humira biosimilar

29 Aug 2017

Cyltezo approved for the treatment of multiple chronic inflammatory diseases.

Read more 
Biopharma stages a strong recovery over the first half even as M&A deals disappoint

Biopharma stages a strong recovery over the first half even as M&A deals disappoint

4 Aug 2017

EP Vantage releases half-year reviews of pharma & biotech and medtech performance.

Read more 
Amgen submits sBLA for Prolia in glucocorticoid-induced osteoporosis

Amgen submits sBLA for Prolia in glucocorticoid-induced osteoporosis

31 Jul 2017

Results from the Phase III study included in the sBLA submission showed that treatment with Prolia for 12 months led to statistically significant greater gains in BMD at the lumbar spine and total hip compared to risedronate.

Read more